Ciloa Sas

Ciloa Sas company information, Employees & Contact Information

Explore related pages

Related company profiles:

Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives. Ciloa bioengineers sEV proteins, to turn them into natural messengers with huge medical potential. Our bioengineered sEVs can be used as therapeutic solutions in a number of medical fields, including oncology, metabolic diseases, rare diseases and age-related illnesses. Mastering sEV engineering, we have produced sEVs containing a stable, highly multimerised and functional adiponectin (APN), a hormone well known as our “Guardian Angel” for its insulin-sensitizing, anti-inflammatory and anti-oxidative stress properties. Ciloa’s platform, EVENGI, has generated over a hundred sEVs containing various proteins of medical interest. Thanks to our 20 years’ experience in the field of EVs, we have developed a robust sEV production, purification and qualification process that can be scaled up under industrial conditions. This EV production platform has enabled us to produce dozens of bioengineered sEVs that are stable in the refrigerator for years as ready-to-use, affordable medicines.

Company Details

Employees
13
Founded
-
Address
356 Rue Maurice Bejart, Montpellier,34080,france
Phone
+33 (0) 467 143 997
Email
co****@****iloa.fr
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
ciloa.fr
HQ
Montpellier
Looking for a particular Ciloa Sas employee's phone or email?

Ciloa Sas Questions

News

Ciloa secures €6.5 million government funding from France 2030 ‘Innovation in biotherapies and biomanufacturing’ to develop drug candidate for treatment of obesity and type 2 diabetes - BioInformant

Ciloa secures €6.5 million government funding from France 2030 ‘Innovation in biotherapies and biomanufacturing’ to develop drug candidate for treatment of obesity and type 2 diabetes BioInformant

Ciloa SAS secures €6.5m to advance lead candidate APN-sEV into clinical development - European Biotechnology Magazine

Ciloa SAS secures €6.5m to advance lead candidate APN-sEV into clinical development European Biotechnology Magazine

French scale-up Ciloa raises €6.5 million to advance exosome therapy for metabolic diseases - EU-Startups

French scale-up Ciloa raises €6.5 million to advance exosome therapy for metabolic diseases EU-Startups

CILOA creates its new GMP-compliant production unit - BioInformant

CILOA creates its new GMP-compliant production unit BioInformant

Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor - Nature

Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor Nature

Ciloa’s project among the 11 winners of the “Sanofi iTech Awards” - BioInformant

Ciloa’s project among the 11 winners of the “Sanofi iTech Awards” BioInformant

Ciloa secures €5 million for the development of its new generation of biomedicines and vaccines using exosomes - BioInformant

Ciloa secures €5 million for the development of its new generation of biomedicines and vaccines using exosomes BioInformant

Exosomes: Company Spotlights from "A" to "Z" - BioInformant

Exosomes: Company Spotlights from "A" to "Z" BioInformant

Top Ciloa Sas Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant